Compare AERO & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AERO | BHVN |
|---|---|---|
| Founded | 1934 | 2013 |
| Country | Mexico | United States |
| Employees | 17068 | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.3B |
| IPO Year | 2023 | 2022 |
| Metric | AERO | BHVN |
|---|---|---|
| Price | $15.95 | $13.94 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | $28.57 | ★ $29.08 |
| AVG Volume (30 Days) | 346.1K | ★ 3.8M |
| Earning Date | 04-21-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 26.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $11.85 | N/A |
| Revenue Next Year | $4.57 | N/A |
| P/E Ratio | $7.95 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.26 | $7.48 |
| 52 Week High | $23.05 | $18.57 |
| Indicator | AERO | BHVN |
|---|---|---|
| Relative Strength Index (RSI) | 58.63 | 49.87 |
| Support Level | $15.85 | $13.56 |
| Resistance Level | $16.67 | $15.42 |
| Average True Range (ATR) | 0.62 | 1.05 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 92.15 | 45.03 |
Grupo Aeromexico SAB de CV engages in providing air transport services for passengers, goods, and cargo, as well as loyalty program services, training and management services, franchise systems commercialization, and the management of investment in shares. Its services include passenger and cargo transportation, the Club Premier loyalty program, training, charter services, and other aviation-related activities. The company operates through a single operating segment, air transportation, and its geographical presence includes both domestic and international markets, with the majority of revenue coming from the international market.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.